Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin. (2022)
Attributed to:
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00596-2021
PubMed Identifier: 35382002
Publication URI: http://europepmc.org/abstract/MED/35382002
Type: Journal Article/Review
Volume: 8
Parent Publication: ERJ open research
Issue: 2
ISSN: 2312-0541